February 4th 2026
Increasing Medicare Advantage payments for full Medicaid enrollees was not associated with meaningful changes in inpatient or nursing home use.
February 3rd 2026
A spending bill advancing PBM reforms aims to delink Medicare Part D compensation from drug rebates and improve pricing transparency.
February 2nd 2026
Patients on commercial insurance were more likely to have at least 1 chronic condition, which can affect health care spending overall.
January 27th 2026
CMS’s 2027 proposed MA payment rate increase of .09% falls short of expectations, potentially increasing premiums and reducing benefits for seniors.
With the CDC’s decision to roll back recommendations to vaccinate for several conditions, questions have arisen as to what that may mean in the US.
Role of Immunotherapy in Lung Cancer
Watch
Deciding on Second-Line Lung Cancer Therapy
Frontline Decision Making in Nondriver Lung Cancer
Outcomes-Based Contracting in Lung Cancer
Cost-Benefit Analysis in Lung Cancer
Current Biomarkers in Lung Cancer
Assessing Options in Second-Line NSCLC
Molecular Testing in NSCLC and Cost
Integrating New Lung Cancer Drugs Into a Formulary
Clinical Pathways in Lung Cancer
5 Elements of a Strategy to Fight Loneliness in Seniors
The integrated health plan has a strategy to combat the effects of isolation and its effects, which increase the risk of Alzheimer's disease, obesity, and hospital readmissions.
Read More
The Future of Healthcare in the United States
How Will an ACA Repeal Affect Healthcare?
The Politics of Healthcare Reform
Navigating Eligibility and Access Issues When Diagnosed
The Balancing Act of Cost vs Access to Care
Role of Health Plans in Medicaid Expansion
ACA, Medicaid Expansion, and Cancer Care
ACA: Effect on Patients With Chronic Conditions
Influence of Value Frameworks in Clinical Practice
Using Reimbursement Models to Overcome Oncology Care Gaps
Developing Appropriate Quality Measures in Oncology
Capturing Meaningful Measures in Cancer
Realizing Patient Goals in Cancer Care
Keeping Oncology Care Patient-Centered
Standardization of Biopsy Testing and Interpreting Data
Genomic Testing for Trial Participation and Access
Engaging Patients in Oncology Trials Is a Team Effort
What Will Patients Gain From the TAPUR Study?
Drug Price Arguments Have No Easy Answer